Evidence map›Paper›PMID 32414138›Full record

ArticleInternational journal of molecular sciences2020

Anna Sadowska, Ewa Zapora, Diana Sawicka, Katarzyna Niemirowicz-Laskowska, Arkadiusz Surażyński, Katarzyna Sułkowska-Ziaja, Katarzyna Kała, Marcin Stocki, Marek Wołkowycki, Sławomir Bakier and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Anna SadowskaDepartment of Experimental Pharmacology, Medical University of Białystok, Szpitalna 37, 15-295 Bialystok, Poland.
Ewa ZaporaInstitute of Forest Sciences, Bialystok University of Technology, Wiejska 45E, 15-351 Bialystok, Poland.
Diana SawickaDepartment of Experimental Pharmacology, Medical University of Białystok, Szpitalna 37, 15-295 Bialystok, Poland.
Katarzyna Niemirowicz-LaskowskaDepartment of Experimental Pharmacology, Medical University of Białystok, Szpitalna 37, 15-295 Bialystok, Poland.ORCID 0000-0002-3311-7147
Arkadiusz SurażyńskiDepartment of Medicinal Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.
Katarzyna Sułkowska-ZiajaDepartment of Pharmaceutical Botany, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0002-7325-9254
Katarzyna KałaDepartment of Pharmaceutical Botany, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0001-8354-211X
Marcin StockiInstitute of Forest Sciences, Bialystok University of Technology, Wiejska 45E, 15-351 Bialystok, Poland.ORCID 0000-0002-9430-7892
Marek WołkowyckiInstitute of Forest Sciences, Bialystok University of Technology, Wiejska 45E, 15-351 Bialystok, Poland.
Sławomir BakierInstitute of Forest Sciences, Bialystok University of Technology, Wiejska 45E, 15-351 Bialystok, Poland.
Anna PawlikDepartment of Biochemistry and Biotechnology, Maria Curie Sklodowska University, Akademicka 19, 20-033 Lublin, Poland.ORCID 0000-0002-2991-758X
Magdalena JaszekDepartment of Biochemistry and Biotechnology, Maria Curie Sklodowska University, Akademicka 19, 20-033 Lublin, Poland.
Bożena MuszyńskaDepartment of Pharmaceutical Botany, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0002-5007-1486
Halina CarDepartment of Experimental Pharmacology, Medical University of Białystok, Szpitalna 37, 15-295 Bialystok, Poland.
Medical University of Białystok · PLBialystok University of Technology · PLJagiellonian University · PLMaria Curie-Skłodowska University · PL

Funding

Medical University of Bialystok, Poland N/ST/MN/18/002/3327Ministry of Science and Higher Education WZ/INL/1/2019
6 · The paper itself

Abstract

Application of substances from medicinal mushrooms is one of the interesting approaches to improve cancer therapy. In this study, we commenced a new attempt in the field of

Indexed as

AnimalsApoptosisBasidiomycotaCell ProliferationColonic NeoplasmsHumansMicePlant ExtractsXenograft Model Antitumor AssaysPlant Extractsactive substancesapoptosiscolon cancerHeterobasidion annosummouse modeltoxicity

Identifiers

PMID32414138
PMCPMC7279362
OpenAlexW3024710215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.